Keyphrases
Protein Level
100%
Glycogen Synthase Kinase 3 (GSK3)
100%
Receptor Signaling
100%
Signal Component
100%
Pathophysiology of Schizophrenia
100%
Dopamine D2 Receptor (DRD2)
100%
Protease-activated Receptor 4 (PAR4)
83%
AKT1
83%
Schizophrenic Patients
66%
Lymphocytes
66%
Frontal Cortex
50%
Australia
33%
Beer
33%
Israel
16%
Healthy Controls
16%
Patient-controlled
16%
Schizophrenia
16%
Bipolar Patients
16%
Signaling Complex
16%
Epstein-Barr Virus
16%
Signaling Cascades
16%
Brain Samples
16%
Mental Hospital
16%
Western Blotting
16%
G Protein
16%
Specificity Protein 1
16%
Desensitization
16%
Postmortem Brain
16%
Dopaminergic Neurotransmission
16%
Arrestin
16%
Arrestin2
16%
Protein Phosphatase 2A (PP2A)
16%
Dephosphorylate
16%
Dopamine-dependent Behaviors
16%
PKA Activity
16%
Brain Bank
16%
Group Support
16%
Medicine and Dentistry
Pathophysiology
100%
Glycogen Synthase Kinase
100%
Dopamine Receptor D2
100%
Lymphocyte
66%
Cell Line
50%
Frontal Lobe
50%
Epstein Barr Virus
16%
Mental Health
16%
Western Blot
16%
Downregulation
16%
Protein
16%
Desensitization
16%
Neurotransmission
16%
Guanine Nucleotide Binding Protein
16%
Retina S Antigen
16%
Neuroscience
Dementia Praecox
100%
Dopamine Receptor D2
100%
GSK-3
75%
AKT1
62%
Lymphocyte
50%
Cell Line
37%
Frontal Lobe
37%
Behavior (Neuroscience)
12%
Protein
12%
Western Blot
12%
G Protein
12%
Neurotransmission
12%
Epstein-Barr Virus
12%
Retina S Antigen
12%
Biochemistry, Genetics and Molecular Biology
GSK-3
100%
Dopamine Receptor D2
100%
AKT1
83%
Lymphocyte
66%
Downregulation
16%
Western Blot
16%
Mental Health
16%
G Protein
16%
Neurotransmission
16%
Arrestin
16%
Epstein Barr Virus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Glycogen Synthase Kinase
100%
Dopamine Receptor D2
100%
Western Blot
16%
Protein
16%
Guanine Nucleotide Binding Protein
16%
Desensitization
16%
Epstein-Barr Virus
16%
Retina S Antigen
16%